Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

Relief Therapeutics seeks US emergency approval for COVID-19 drug

Relief Therapeutics seeks US emergency approval for COVID-19 drug

If granted, EUA would give approval for use in severely ill patients with no other treatment options. ... The EUA application covers the same type of patients whom FDA has already allowed to receive treatment under the Expanded Access protocol authorised

Latest news

  • Mesoblast expands compassionate use COVID-19 programme Mesoblast expands compassionate use COVID-19 programme

    COVID-19 who experience cardiovascular and other complications of multisystem inflammatory syndrome, thanks to the new expanded access protocol. ... Expanded access is a potential pathway for patients who have an immediate, life-threatening condition to

  • The mother of all nudges The mother of all nudges

    Many readers may be familiar with my views on the subject and, specifically, how the practice of seeking health information online can adversely affect access to care, treatment decisions and allocation ... The COVID-19 pandemic has heightened my

  • FDA grants emergency authorisation to chloroquine for COVID-19 FDA grants emergency authorisation to chloroquine for COVID-19

    Although the drug has now been approved for emergency use, this authorisation only applies to certain COVID-19 patients, who must meet specific criteria to access the treatment. ... the treatment of COVID-19," said Luciana Borio in a tweet earlier today.

  • SMC enables access to Kyowa Kirin’s Crysvita for rare bone disease SMC enables access to Kyowa Kirin’s Crysvita for rare bone disease

    Drug is being reviewed under new ultra-orphan pathway. The Scottish Medical Consortium has enabled access to Japanese pharma Kyowa Kirin's Crysvita, a novel treatment for a rare inherited bone ... Access to a treatment that tackles the underlying

  • Novartis plans inclisiran trial in the UK Novartis plans inclisiran trial in the UK

    In January, Novartis announced that it has teamed up with the NHS which will see patients in England receive accelerated access to inclisiran upon regulatory approval. ... The proposed population-level agreement would provide access to inclisiran

More from news
Approximately 1 fully matching, plus 217 partially matching documents found.

Latest Intelligence

  • New truths and realities in these strange times New truths and realities in these strange times

    The issue may be as simple as not being able to access their physician/GP in the usual manner, not having the usual access to their medications as regularly (if at ... Patients are also worried about access to care or treatment; the difficulties of

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    It will take multiple evolutions before we get an AD treatment equivalent to today’s smartphones. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.

  • A market-adapted agile approach to launch excellence A market-adapted agile approach to launch excellence

    relevance. 2. Less white space product differentiation. In crowded disease areas where compounds may show only incremental benefit, payers often make cross-product comparisons, differentiating and restricting treatment access. ... tactics for bolder

  • A snapshot of Congenica A snapshot of Congenica

    Receiving a diagnosis can help to facilitate access to treatment and eliminate the need for further tests. ... Finally, in an industry that is driven by genomic and health data we provide users with access to a vast array of public and private databases.

  • Case study: OptiMiSe for MS nurses Case study: OptiMiSe for MS nurses

    At that time, challenges faced by MSSNs were deemed to be impacting patient access to recommended care – potentially leading to delays in receiving treatment that reduce relapses and disability. ... identifying patients needing treatment changes, to

More from intelligence
Approximately 1 fully matching, plus 51 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • If our patients are diverse, why are clinical trials so white?

    As a result, it’s very likely that only wealthier people from urban areas will begin their treatment journey at these larger research institutions with the proper resources for and access ... Ninlaro is an oral treatment for multiple myeloma indicated

  • Are biobetters a market access opportunity?

    Ensuring market access for biobetters. Biobetters provide stepped up value to patients, such as increased convenience and further treatment options should disease progression occur. ... To achieve this, biobetters must address an unmet patient need or

  • EPG Health EPG Health

    Majoring in customer-centric website design and personalised user journeys, Medthority provides a trusted learning environment with convenient access to content that supports HCP treatment decisions and patient outcomes. ... Optimise content for digital

  • The fight against COVID-19 needs to have diversity at the heart of its strategy The fight against COVID-19 needs to have diversity at the heart of its strategy

    Their report goes further than just looking at key workers, and reveals evidence that reduced access to health treatment compared with white people, the impact of school closures, lower income and ... Overlooking this will mean that there’s yet another

  • How do companies prepare for reimbursement?

    For example, mixed treatment analysis will help to understand current clinical unmet need. ... These elements are clear markers of discrepancies between commercial and market access strategies.

More from PMHub
Approximately 0 fully matching, plus 28 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics